Retraction
MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
Paper Information
Record ID:
42409
Author(s):
Journal:
Publication Date:
February 16, 2022
Retraction Date:
January 26, 2023
(2.8 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (9)
9
Total Citations4
Post-Retraction(44.4%)
4
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
0
After 2+ years
302
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma
Yoko Hagihara, Yuya Tomioka, Takayuki Suetsugu et al. (11 authors)
Cancers
Open Access
Published: Nov 2023
6 citations
6 citations
302 days after retraction
TPD52 is a Potential Prognostic Biomarker and Correlated with Immune Infiltration: A Pan-cancer Analysis
Miao Lu, Li Jing, Buze Chen et al. (5 authors)
Current Molecular Medicine
Published: Oct 2023
266 days after retraction
MicroRNA-139-5p suppresses non-small cell lung cancer progression by targeting ATAD2
Tong Sun, Zhaoyu Liu
Pathology - Research and Practice
Published: Jul 2023
4 citations
4 citations
182 days after retraction
Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
Afshin Taheriazam, Seyedeh Delaram Bayanzadeh, Melika Heydari Farahani et al. (17 authors)
European Journal of Pharmacology
Published: May 2023
9 citations
9 citations
105 days after retraction
Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers
Giovanni Tossetta, Daniela Marzioni
European Journal of Pharmacology
Published: Jan 2023
69 citations
69 citations
15 days before retraction
Retracted: MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
25 days before retraction
Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
Tongyu Meng, Qingfeng Wang, Yufeng Yang et al. (5 authors)
Frontiers in Genetics
Open Access
Published: Apr 2022
8 citations
8 citations
289 days before retraction
Role of NRF2 in Ovarian Cancer
Giovanni Tossetta, Sonia Fantone, Eva Montanari et al. (5 authors)
Antioxidants
Open Access
Published: Mar 2022
93 citations
93 citations
302 days before retraction
Quick Stats
Total Citations:
15
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025